Furthermore, apoC-I may be linked to cardiovascular risk through HDL-independent mechanisms, given its regulatory roles across diverse aspects of cardiovascular physiology, including inflammation, immunity, sepsis, diabetes, cancer and viral infectivity [40]. This evidence concerns the gene APOC1 and cancer.